| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/01/2004 | EP1452855A1 Gas sensor, and production method for gas sensor |
| 09/01/2004 | EP1452854A1 Fail judging method for analysis and analyzer |
| 09/01/2004 | EP1452853A1 Gas sensor |
| 09/01/2004 | EP1452606A1 Method for measurement using sodium azide |
| 09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/01/2004 | EP1452599A1 Improved epitope displaying phage |
| 09/01/2004 | EP1452598A1 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 09/01/2004 | EP1452594A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof |
| 09/01/2004 | EP1452590A1 Stereostructure of dna recombination repair enzyme and utilization thereof |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452541A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 09/01/2004 | EP1452291A1 Method and device for cleaning thermoplastic resinous products |
| 09/01/2004 | EP1452239A1 Immobilizing device |
| 09/01/2004 | EP1451755A2 Methods and apparatus for complex genetics classification based on correspondence analysis and linear/quadratic analysis |
| 09/01/2004 | EP1451750A2 Method for the identification of pharmacophores |
| 09/01/2004 | EP1451674A2 Method and apparatus for parallel dispensing of defined volumes of solid particles |
| 09/01/2004 | EP1451595A2 Electrodynamic sensors and applications thereof |
| 09/01/2004 | EP1451590A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 09/01/2004 | EP1451589A2 Methods and apparatus for blood typing with optical bio-discs |
| 09/01/2004 | EP1451588A2 Sensitive coded detection systems |
| 09/01/2004 | EP1451587A2 Antigen panels and methods of using the same |
| 09/01/2004 | EP1451586A1 Method and device for determining a concentration of ligands in an analysed sample |
| 09/01/2004 | EP1451585A2 A novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein |
| 09/01/2004 | EP1451583A2 Method for performing in vitro diagnosis using gene regulation mechanisms and corresponding diagnosis kit |
| 09/01/2004 | EP1451582A1 Device and method for microchip based enzyme linked immunosorbent assay (elisa) |
| 09/01/2004 | EP1451581A2 Toll-like receptor 3 signaling agonists and antagonists |
| 09/01/2004 | EP1451580A2 Method of using physiological markers to estimate cardiovascular risk |
| 09/01/2004 | EP1451579A2 Method of using a non-antibody protein to detect and measure an analyte |
| 09/01/2004 | EP1451578A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 09/01/2004 | EP1451577A2 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases |
| 09/01/2004 | EP1451575A2 Method and apparatus for detecting the presence of ammonium nitrate and a sugar or a hydrocarbon |
| 09/01/2004 | EP1451574A1 Method for measuring concentration of chloroisocyanuric acid derivatives in water |
| 09/01/2004 | EP1451573A1 Method and device for measuring animal meat tenderness or fish freshness |
| 09/01/2004 | EP1451572A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 09/01/2004 | EP1451555A1 A method of determining the content of s0 2 in a beverage product |
| 09/01/2004 | EP1451554A1 Hydrophobic surface chip |
| 09/01/2004 | EP1451552A2 Reagents and methods useful for detecting diseases of the breast |
| 09/01/2004 | EP1451551A4 Contact potential difference sensor to monitor oil properties |
| 09/01/2004 | EP1451551A2 Contact potential difference sensor to monitor oil properties |
| 09/01/2004 | EP1451377A2 Assay for identifying anti-viral agents specific for protein-coated double-stranded dna viruses |
| 09/01/2004 | EP1451376A2 A coated film laminate having an electrically conductive surface |
| 09/01/2004 | EP1451375A2 Phage ligand sensor devices and uses thereof |
| 09/01/2004 | EP1451374A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays |
| 09/01/2004 | EP1451373A1 System for detecting biological materials in a sample |
| 09/01/2004 | EP1451372A1 System and method for temperature gradient capillary electrophoresis |
| 09/01/2004 | EP1451369A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 09/01/2004 | EP1451368A2 Single nucleotide polymorphisms in gh-1 |
| 09/01/2004 | EP1451364A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 09/01/2004 | EP1451358A2 Cell and tissue arrays and microarrays and methods of use |
| 09/01/2004 | EP1451357A1 Biocatalytic solgel microarrays |
| 09/01/2004 | EP1451356A1 Method and kit for proximity probing with multivalent proximity probes |
| 09/01/2004 | EP1451352A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna |
| 09/01/2004 | EP1451351A2 Labelled nucleotides |
| 09/01/2004 | EP1451348A2 Methods, reagents, kits and apparatus for protein function analysis |
| 09/01/2004 | EP1451347A2 Identification of genes involved in restenosis and in atherosclerosis |
| 09/01/2004 | EP1451345A1 Age-associated markers |
| 09/01/2004 | EP1451343A2 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| 09/01/2004 | EP1451342A1 Low molecular weight heparin assay, system and reagent therefor |
| 09/01/2004 | EP1451341A2 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 09/01/2004 | EP1451340A1 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| 09/01/2004 | EP1451339A2 Liquid interface configurations for automated patch clamp recording |
| 09/01/2004 | EP1451338A1 Recombinant antibodies for the detection and neutralization of anthrax toxin |
| 09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451324A2 G-protein coupled receptor lustr2 and uses thereof |
| 09/01/2004 | EP1451318A1 Compilations of nucleic acids and arrays and methods of using them |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451304A2 Kits and methods for preparing cell samples optimized for dual staining |
| 09/01/2004 | EP1451303A1 Detection of haematopoietic stem cells and progeny and uses thereof |
| 09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
| 09/01/2004 | EP1451291A2 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 09/01/2004 | EP1451225A1 Agonists of recombinant human histamine h3 receptor |
| 09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 09/01/2004 | EP1451220A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451218A2 Methods for the treatment and prognosis of leukemia and other cancer types |
| 09/01/2004 | EP1451216A1 Immunointeractive molecules and uses thereof |
| 09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1451207A2 Labeling reagent and methods of use |
| 09/01/2004 | EP1451206A2 Process for the selective alkylation of -sh groups in proteins and peptides for the study of complex protein mixtures |
| 09/01/2004 | EP1451155A1 Compositions, methods and kits pertaining to luminescent compounds |
| 09/01/2004 | EP1450957A1 Method and apparatus for high-throughput sample handling process line |
| 09/01/2004 | EP1450952A1 Method and apparatus for transporting biological samples |
| 09/01/2004 | EP1450859A2 Methods and compositions for the diagnosis of asthma |
| 09/01/2004 | EP1450845A2 15603, a human ion channel family member |
| 09/01/2004 | EP1450830A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
| 09/01/2004 | EP1450775A2 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 09/01/2004 | EP1450677A1 Reagent-less whole-blood glucose meter |
| 09/01/2004 | EP1450666A2 Methods and compositions to treat cardiovascular disease using 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 or 93804 |
| 09/01/2004 | EP1450602A2 Identifying and characterizing genes |
| 09/01/2004 | EP1303534A4 Promyostatin peptides and methods of using same |
| 09/01/2004 | EP1287112B1 Preparing a sample to be analysed from a sample with very large volume |
| 09/01/2004 | EP1244749B1 Mobility-modifying cyanine dyes |
| 09/01/2004 | EP1210602B1 Method of diagnosing sjögren's syndrome |
| 09/01/2004 | EP1165135B1 Methods of screening for compounds modulating fxr receptors |
| 09/01/2004 | EP1123508B1 Method for measuring cellular adhesion |
| 09/01/2004 | EP1071949B1 Method for determining a gushing factor for a beverage |
| 09/01/2004 | EP1064533B1 Device and method for directly measuring calorific energy contained in a fuel gas |
| 09/01/2004 | EP1029241B1 Process for determining cell vitality and efficiency in parallel after a gene transfer into eukaryotic cells and dual test system |